Dapsone for primary immune thrombocytopenia in adults and children: an evidence-based review.
about
How we manage immune thrombocytopenia in the elderly.Emerging drugs for immune thrombocytopenia (ITP).Dapsone therapy for refractory immune thrombocytopenia patients: a case series.Dapsone therapy for immune thrombocytopenic purpura: old but still unfamiliar.Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.Disappointing response to dapsone as second line therapy for primary ITP: a case series.
P2860
Dapsone for primary immune thrombocytopenia in adults and children: an evidence-based review.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Dapsone for primary immune thr ...... ren: an evidence-based review.
@ast
Dapsone for primary immune thr ...... ren: an evidence-based review.
@en
type
label
Dapsone for primary immune thr ...... ren: an evidence-based review.
@ast
Dapsone for primary immune thr ...... ren: an evidence-based review.
@en
prefLabel
Dapsone for primary immune thr ...... ren: an evidence-based review.
@ast
Dapsone for primary immune thr ...... ren: an evidence-based review.
@en
P2860
P356
P1476
Dapsone for primary immune thr ...... dren: an evidence-based review
@en
P2093
L Gooneratne
P2860
P304
P356
10.1111/JTH.12371
P577
2013-11-01T00:00:00Z